HCSS, under CEO Dr Heah Sieu Min, focuses on endoscopic procedures.
For the most recent financial year ended June 30 2025, Chirurgia, an entity used by Dr Lee to own LS Lee Surgery, recorded a net profit before tax of some $495,000.
As at June 30, the net tangible asset value and the net asset value of Chirurgia were both $1,241,000.
Following the initial 51% stake, Dr Lee will sell the remaining 49% to HCSS by Nov 30 2029. In the meantime, he will manage Chirurgia for an initial period of ten years starting from April 7.
See also: Japan’s Nikkon said to weigh going private with US funds to bid
HCSS shares last traded at 37 cents, up 2.78% year to date.
Scroll to continue
